Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
Meta Platforms (Facebook)
META
|
+$446M |
| 3 |
Johnson & Johnson
JNJ
|
+$306M |
| 4 |
Evergy
EVRG
|
+$288M |
| 5 |
Walmart Inc
WMT
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$596M |
| 2 |
Booking.com
BKNG
|
+$519M |
| 3 |
Amazon
AMZN
|
+$518M |
| 4 |
Eli Lilly
LLY
|
+$268M |
| 5 |
UnitedHealth
UNH
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.51% |
| 2 | Technology | 14.39% |
| 3 | Financials | 11.76% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Real Estate | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Align Technology
ALGN
$12.5B
| $990M | 1.08% |
2,894,800
-63,800
| -2% | -$19M |
|
2
Domino's
DPZ
$10.7B
| $974M | 1.06% |
3,451,500
-80,600
| -2% | -$20.4M |
|
3
VeriSign
VRSN
$23.8B
| $950M | 1.04% |
6,915,100
-11,776
| -0.2% | -$1.51M |
|
|
NVO
4
Novo Nordisk
NVO
$214B
| $883M | 0.96% |
38,284,600
+4,102,000
| +12% | +$97.5M |
|
5
Humana
HUM
$47.8B
| $828M | 0.9% |
2,783,500
-465,600
| -14% | -$136M |
|
|
VMW
6
DELISTED
VMware, Inc
VMW
| $777M | 0.85% |
5,289,800
+1,512,500
| +40% | +$209M |
|
7
Palo Alto Networks
PANW
$273B
| $766M | 0.83% |
22,354,200
-4,322,400
| -16% | -$144M |
|
8
PepsiCo
PEP
$185B
| $758M | 0.83% |
6,962,850
-2,115,412
| -23% | -$219M |
|
|
9
Apple
AAPL
$4.76T
| $707M | 0.77% |
+15,275,332
| New | +$693M |
|
10
Amgen
AMGN
$198B
| $702M | 0.77% |
3,803,600
-121,700
| -3% | -$21.5M |
|
11
Vertex Pharmaceuticals
VRTX
$120B
| $688M | 0.75% |
4,050,617
+1,199,700
| +42% | +$186M |
|
|
ABMD
12
DELISTED
Abiomed Inc
ABMD
| $635M | 0.69% |
1,551,423
+401,800
| +35% | +$146M |
|
13
Bristol-Myers Squibb
BMY
$124B
| $584M | 0.64% |
10,547,200
-3,981,100
| -27% | -$215M |
|
14
Crown Castle
CCI
$33.7B
| $570M | 0.62% |
5,289,703
-491,200
| -8% | -$51M |
|
15
Intuitive Surgical
ISRG
$121B
| $562M | 0.61% |
3,523,230
-922,800
| -21% | -$141M |
|
16
Cboe Global Markets
CBOE
$29.6B
| $540M | 0.59% |
5,190,200
+683,700
| +15% | +$72.2M |
|
|
17
Meta Platforms (Facebook)
META
$1.6T
| $479M | 0.52% |
+2,467,488
| New | +$446M |
|
18
Idexx Laboratories
IDXX
$43.3B
| $473M | 0.52% |
2,169,929
+81,025
| +4% | +$16.7M |
|
19
Dell
DELL
$287B
| $469M | 0.51% |
19,774,902
+2,832,062
| +17% | +$62.6M |
|
20
Colgate-Palmolive
CL
$73.4B
| $467M | 0.51% |
7,200,900
-2,022,700
| -22% | -$132M |
|
|
21
Johnson & Johnson
JNJ
$615B
| $454M | 0.49% |
3,740,300
+2,455,901
| +191% | +$306M |
|
22
FirstEnergy
FE
$28.6B
| $431M | 0.47% |
12,007,408
+2,251,708
| +23% | +$77.1M |
|
23
Progressive
PGR
$119B
| $420M | 0.46% |
7,094,900
+1,163,500
| +20% | +$71.2M |
|
24
BP
BP
$112B
| $414M | 0.45% |
9,623,315
+1,720,781
| +22% | +$72.3M |
|
25
Best Buy
BBY
$18.3B
| $394M | 0.43% |
5,279,100
-264,000
| -5% | -$19.5M |
|
Similar funds
Renaissance Technologies's Q2 2018 Portfolio in Review
As of Q2 2018, Renaissance Technologies held 3,750 positions worth $91.7B, up 0.34% from $91.4B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies withdrew a net $3.9B in Q2 2018, closing 524 positions and reducing 1,111 holdings. Its most notable exit was Booking.com, an estimated $519M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, Renaissance Technologies opened a new position in Apple worth $707M.
- Renaissance Technologies's largest Q2 2018 buy was Apple: 15,275,332 shares worth $707M.
- Renaissance Technologies added most to Johnson & Johnson in Q2 2018, an estimated $306M increase.
- Renaissance Technologies's biggest Q2 2018 reduction was Home Depot, cutting an estimated $596M.
- Renaissance Technologies fully exited Booking.com in Q2 2018, selling an estimated $519M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $91.7B portfolio in Q2 2018.
- Renaissance Technologies opened 412 new positions and closed 524 in Q2 2018.
- Renaissance Technologies's portfolio value rose 0.34% quarter-over-quarter to $91.7B.
Based on Renaissance Technologies's 13F filing for Q2 2018, filed 13 Aug 2018.